Gallagher Neil 4
4 · Syndax Pharmaceuticals Inc · Filed Apr 12, 2023
Insider Transaction Report
Form 4
Gallagher Neil
President, Head of R&D
Transactions
- Award
Stock Options (Right to buy)
2023-04-10$19.35/sh+250,000$4,837,500→ 250,000 totalExercise: $19.35Exp: 2033-04-10→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on April 10, 2024, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.